Are we reading different releases, this is only a daily dose trial. Standard treatment is 3x daily. P values at 3x are way better
"Having demonstrated protective efficacy in two published clinical studies (Otto et al., 2011), this Phase 2 study wasdesigned to compare the preventative effects of once daily dosing to the current standard recommended treatmentof three times daily dosing."
"Travelan® demonstrated clinical efficacy in preventing ETEC-attributable diarrhea in two previous CHIM studies. Thesestudies showed dosing 400 mg three times daily, resulted in 76.7% (p=0.007) to 90.9% (p=0.0005) protection (Otto etal., 2011)."
Are we reading different releases, this is only a daily dose...
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.0¢ |
Change
-0.007(7.22%) |
Mkt cap ! $20.52M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.7¢ | 9.0¢ | $79.65K | 850.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 210635 | 9.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.3¢ | 3318 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.2¢ |
Change
-0.007 ( 5.15 %) |
||||
| Open | High | Low | Volume | ||
| 9.4¢ | 9.4¢ | 9.2¢ | 112182 | ||
| Last updated 15.43pm 09/05/2024 ? | |||||
| IMC (ASX) Chart |